Profiles

A medicinal chemist with extensive experience in the area of thrombosis, Song specializes in designing and synthesizing small molecules as drug candidates for disease targets. During the eight years that Song has worked at Portola, he has been an integral part of the drug discovery team that advanced Portola’s compounds, betrixaban and elinogrel, into clinical trials. In addition, he has played an instrumental role in building Portola’s robust drug discovery pipeline. “It is gratifying to be part of a team that is making a meaningful contribution to Portola’s future success.”